Heyu Biological Technology Corp

Chart & Performance

D1W1MN

P/E

—

P/S

2.62

EPS

—

Div Yield, %

—

Shrs. gr., 5y

99.75%

Rev. gr., 5y

Revenues

79k

-18.16%

Net income

-265k

L+62.79%

CFO

-292k

L+107.09%

Profile

Heyu Biological Technology Corporation, together with its subsidiaries, engages in research, development, and manufacturing of healthcare equipment. It is currently focused on developing Submillimeter Wave (Terahertz) Quantized Space Therapy Chamber, a medical equipment designed to treat cancer through cold nuclear fusion caused by cosmic ray muons in an enclosed chamber. The company was formerly known as Pacific WebWorks, Inc. and changed its name to Heyu Biological Technology Corporation in June 2018. Heyu Biological Technology Corporation was incorporated in 1987 and is based in Xiamen, the People's Republic of China.

URL

https://heyubt.com

IPO date

Nov 05, 1999

Employees

Domiciled in

Incorporated in

Valuation

Order:

Title USD in thousands, except ratios and share amounts	FY	FY	FY	FY	FY	FY	FY	FY
Title USD in thousands, except ratios and share amounts	2022‑12	2021‑12	2020‑12	2019‑12	2018‑12	2017‑12	2016‑12	2015‑12
Income
Revenues	79 -18.16%
Cost of revenue	345
Unusual Expense (Income)
NOPBT	(266)
NOPBT Margin
Operating Taxes	(200)
Tax Rate
NOPAT	(266)
Net income	(265) 62.79%
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities	451
Net debt	(11)
Cash flow
Cash from operating activities	(292)
CAPEX
Cash from investing activities
Cash from financing activities	196
FCF	(45)
Balance
Cash	11
Long term investments
Excess cash	7
Stockholders' equity	(19,122)
Invested Capital	17,149
ROIC
ROCE	13.47%
EV
Common stock shares outstanding	1,032,466
Price
Market cap
EV
EBITDA	(266)
EV/EBITDA
Interest	200
Interest/NOPBT